data
query
queries
{
"author": {
"name": "Anna Edney",
"webUrl": "/author/profile/anna-edney/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 133,
"social": [],
"articles": [
{
"uri": "/2018/07/18/fda-wants-to-make-more-drugs-available-without-a-p/",
"title": "FDA wants to make more drugs available without a prescription",
"byline": "Anna Edney",
"kicker": "News",
"prettyDate": "July 18, 2018",
"timeToRead": "1 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/PrescriptionDrugs.jpg",
"width": "600",
"height": "400"
},
"authors": [
{
"webUrl": "/author/profile/anna-edney/",
"name": "Anna Edney"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "Patients could answer questions on a mobile-phone app to help determine whether they should be able to access a medication without a prescription.",
"body": null
},
{
"uri": "/2018/06/27/fda-approves-first-marijuana-based-medical-treatme/",
"title": "FDA approves first marijuana-based medical treatment",
"byline": "Anna Edney",
"kicker": "News",
"prettyDate": "June 27, 2018",
"timeToRead": "1 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/04/bloomberg-cannabis-marijuana-pot.jpg",
"width": "650",
"height": "433"
},
"authors": [
{
"webUrl": "/author/profile/anna-edney/",
"name": "Anna Edney"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "The drug, made from cannabidiol compounds found in marijuana, will be used to treat two rare forms of childhood epilepsy,",
"body": null
},
{
"uri": "/2018/06/13/mcconnell-gop-senators-back-pre-existing-condition/",
"title": "McConnell, GOP Senators back pre-existing condition coverage",
"byline": "Anna Edney and Steven T. Dennis",
"kicker": "News",
"prettyDate": "June 13, 2018",
"timeToRead": "1 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/06/DonkeyElephantBalance.jpg",
"width": "600",
"height": "360"
},
"authors": [
{
"webUrl": "/author/profile/anna-edney/",
"name": "Anna Edney"
},
{
"webUrl": "/author/profile/steven-t-dennis/",
"name": "Steven T. Dennis"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "Republicans are already on shaky ground before the mid-term elections, and the loss of one of the most popular parts of the ACA might be a death knell.",
"body": null
},
{
"uri": "/2018/06/12/fda-clears-way-for-outcome-based-insurer-payments/",
"title": "HHS secretary Azar calls for 'a system without rebates'",
"byline": "Anna Edney",
"kicker": "News",
"prettyDate": "June 12, 2018",
"timeToRead": "1 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2017/12/11PriceDrugs.jpg",
"width": "600",
"height": "404"
},
"authors": [
{
"webUrl": "/author/profile/anna-edney/",
"name": "Anna Edney"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "“Such a system's incentives, detached from artificial list prices, would likely serve patients far better,” Azar said in a hearing.",
"body": null
},
{
"uri": "/2018/05/31/price-cuts-to-be-unveiled-in-two-weeks-trump-says/",
"title": "Drug price cuts to be unveiled in two weeks, Trump says",
"byline": " Anna Edney and Justin Sink ",
"kicker": "News",
"prettyDate": "May 31, 2018",
"timeToRead": "1 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/DrugCosts2.jpg",
"width": "616",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/anna-edney/",
"name": "Anna Edney"
},
{
"webUrl": "/author/profile/justin-sink/",
"name": "Justin Sink"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "“I think people are going to start to see for the first time ever in this country a major drop in the cost of prescription drugs,” Trump said.",
"body": null
},
{
"uri": "/2018/05/16/government-drug-price-disclosure-confirms-it-costs/",
"title": "Government drug price disclosure confirms it: costs are soaring",
"byline": "Robert Langreth and Anna Edney",
"kicker": "Market Insights",
"prettyDate": "May 16, 2018",
"timeToRead": "4 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/05/DrugPricesShadow.jpg",
"width": "616",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/robert-langreth/",
"name": "Robert Langreth"
},
{
"webUrl": "/author/profile/anna-edney/",
"name": "Anna Edney"
}
],
"kickerNode": [
{
"uri": "/market-insights/",
"sectionName": "Market Insights"
}
],
"summary": "In an attempt to shame drugmakers into keeping list prices down, a new federal dashboard highlights drugs with particularly rapid increases in unit costs.",
"body": null
},
{
"uri": "/2018/05/11/trump-drug-price-cut-proposal-promises-immediate-i/",
"title": "Trump proposal to cut drug prices promises immediate impact",
"byline": "Anna Edney",
"kicker": "News",
"prettyDate": "May 11, 2018",
"timeToRead": "6 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/05/TrumpBloomberg.jpg",
"width": "600",
"height": "399"
},
"authors": [
{
"webUrl": "/author/profile/anna-edney/",
"name": "Anna Edney"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "American Patients First aims to increase competition for medicines and reduce patients' out-of-pocket costs.",
"body": null
},
{
"uri": "/2018/05/07/kill-drug-patents-to-quell-the-opioid-epidemic/",
"title": "Kill drug patents to quell the opioid epidemic?",
"byline": "Christopher Yasiejko and Anna Edney",
"kicker": "Commentary",
"prettyDate": "May 07, 2018",
"timeToRead": "6 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/05/DrugRX.jpg",
"width": "600",
"height": "400"
},
"authors": [
{
"webUrl": "/author/profile/christopher-yasiejko/",
"name": "Christopher Yasiejko"
},
{
"webUrl": "/author/profile/anna-edney/",
"name": "Anna Edney"
}
],
"kickerNode": [
{
"uri": "/commentary/",
"sectionName": "Commentary"
}
],
"summary": "By overriding patents for opioid antidotes, the government could lower the costs and increase availability of the life-saving drugs.",
"body": null
},
{
"uri": "/2018/05/04/should-the-government-outlaw-drug-plan-rebates/",
"title": "Should the government outlaw drug-plan rebates?",
"byline": "Anna Edney",
"kicker": "News",
"prettyDate": "May 04, 2018",
"timeToRead": "2 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/DrugPrices.jpg",
"width": "600",
"height": "400"
},
"authors": [
{
"webUrl": "/author/profile/anna-edney/",
"name": "Anna Edney"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "Commissioner Scott Gottlieb asked in a speech what would happen if the U.S. government re-examined the safe harbor that drug rebates have.",
"body": null
},
{
"uri": "/2018/04/23/drugmaker-group-sets-lobbying-record/",
"title": "Drugmaker group sets lobbying record",
"byline": "Ben Brody and Anna Edney",
"kicker": "News",
"prettyDate": "April 23, 2018",
"timeToRead": "3 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/DrugCosts2.jpg",
"width": "616",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/ben-brody/",
"name": "Ben Brody"
},
{
"webUrl": "/author/profile/anna-edney/",
"name": "Anna Edney"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "The Pharmaceutical Research and Manufacturers of America spent $9.96 million on federal lobbying in the first three months of 2018.",
"body": null
}
]
}
}